sampling blood
Other3 types of sampling : urine, skin and blood.
NCT Number: NCT07099066
The aim of this research is to establish different cell banks from patients with amyotrophic lateral sclerosis (ALS).
Trial opening soon.
Get Notified18 year and older
All sexes
Observational
The objective of this research is to:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
3 types of sampling : urine, skin and blood.
Time frame: 8 months
Number of cell batches cryopreserved that meet predefined quality criteria (cell viability ≥ 80%, absence of mycoplasma). Data will be summarized as percentage of compliant batches over total batches produced.
Human Cell Design
Industry
Generation of Skin Fibroblast Banks, Urine-derived Cells and Biomarker Isolation From Patients With Amyotrophic Lateral Sclerosis (Als)
Acronym: HCD-SLA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07706270
Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS)
View Trial DetailsNCT07606235
Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS)
View Trial DetailsNCT07454733
Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS)
Scottsdale, Arizona, United States
View Trial DetailsNCT06968468
Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS)
Boston, Massachusetts, United States
View Trial Details